Drug Approval | December 16, 2021
Sun gets US FDA approval for generic amphotericin B injection
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains in older and younger adults, even at lowest dose; no significant safety concerns were observed
The total cost of the project is estimated at Rs 30 crore
MeMed BV is a first-of-its-kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
The approval allows it to market its products in the country
The study was conducted in patients with mild to moderate COVID-19
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
The Department of Pharma has allocated this drug amongst the states/UTs based on expected supply that will be available from May 10 to May 31, 2021
Subscribe To Our Newsletter & Stay Updated
